Gynecology Cancer Clinical Trials

The most recent listing of current clinical trials for gynecological cancers — including cervix, endometrium, ovarian, vulva and vagina — appears below.  

Site: Gynecology (Includes Cervix, Endometrium,Ovarian, Vulva and Vagina)

Protocol ID    Title

   A European Study on MRI-Guided Brachytherapy in Locally Advanced Cervical Cancer

   A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paxlitaxel or CT-2103 (IND #70177) versus No Treatment Until Documented Relapse in Women with Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer Who Achieve a Complete Response to Primary Platinum/Taxane Chemotherapy

   A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone in Combination with Bevacizumab (NSC #704965, IND #7921) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer

   Can Diet and Exercise Modulate Ovarian, Fallopian Tube or Peritoneal Cancer Progression-Free Survival

   The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and Impact in Newly Diagnosed Patients

   A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma

   Randomized Phase III Clinical Trial Of Adjuvant Radiation Versus Chemoradiation In Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy And Pelvic Lymphadenectomy

GOG-0273    Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

   A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: the OUTBACK TRIAL

   A Phase III Randomized Trial of Gemcitabine (NSC # 613327) plus Docetaxel (NSC # 628503) followed by Doxorubicin (NSC # 123127) versus Observation for Uterus-Limited, High-Grade Uterine Leiomyosarcoma

   A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer following First Line Platinum Based Chemotherapy

   A Phase I Study of Intraperitoneal Egen-001 Administered in Combination With Pegylated Liposomal-Doxorubicin in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

   T Regulatory Cells in Early Endometrial Cancer Before and After Treatment

   A Study of MK-1775 in Combination with Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Adult Patients with Platinum Sensitive p53 Mutant Ovarian Cancer